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Biocidal products are Active Substances (AS)
and preparations containing one or more AS,
put up in the form in which they are supplied
to the user, intended to destroy, deter, render
harmless, prevent the action of, or otherwise
exert a controlling effect on any harmful organ-
ism by chemical or biological means (EC, 1998).
Biocides are used in a vast and steadily gro-
wing number of applications from foodstuffs
to paints and marine construction (e.g. Water-
man et al., 2005; Raczek, 2005). However, despi-
te the growing number of applications the
number of available biocide chemistries i.e.
Active Substances (AS) is decreasing in the
European Union (EU) concurrent with the
implementation of the Biocidal Product Directi-
ve (BPD) 98/8/EC (EC, 1998; EC, 2003). Moreo-
ver, other restrictions due to the acknowled-
ged toxicity and/or eco-toxicity of AS such as
Tri Butyl Tin (TBT) in antifouling products or
Copper Chromium Arsenic (CCA) for wood pre-
servation have created voids on the biocide
market (Bruns et al., 2005). Currently, safer
replacements for the out-phased AS are scree-
ned for from the existing selection of AS or
from the use and development of alternative
non-biocidal approaches. Thus, on one hand
demands for eco-efficiency may render pro-
duct raw materials more susceptible to biode-
terioration, whereas on the other hand, there
is increased concern of development of resis-
tance of target organisms to the existing
selection of AS (Maillard, 2002). Accordingly,
current trends pose significant challenges to
the development of new AS, where profitabi-
lity and costs due to EU regulation is also a
major issue (Bruns et al., 2005).
Current EU regulatory initiatives aim at dri-
ving the chemical industry towards more envi-
ronmentally friendly, sustainable and safe pro-
ducts and processes as well to concurrently
foster innovations within the EU markets (EC,
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2006; EC, 1998). The role of regulations as
drivers of innovations in the chemical indus-
try is evident (Frohwein and Hansjürgens,
2005), and e.g. initiatives such as the Mont-
real protocol have boosted the development
of more environmentally safe product alter-
natives (Bonnet and Lacroix, 2006). Moreover,
the presently implemented EU directive 2004/
42/ EC on paints, sets ambitious targets for
striving towards the development of low Vola-
tile Organic Compound (VOC) paints (Mast et
al., 2008). On the other hand, in many areas of
innovative technologies, regulatory initiati-
ves lag behind technology development (Nie-
minen et al., 2004). This may lead into situa-
tions in which the prevailing technologies are
out phased due to regulatory risk reduction
although safer replacements are not yet avai-
lable, e.g. decades after the ban on DDT, no suc-
cessful replacement for all usages is available
to date (Coleman et al., 2008). Such may also
be the case with formaldehyde and its deriva-
tives, which are widely used biocides with
excellent efficacy properties (Power, 1997), but
with risk classification as toxic, potential car-
cinogen and irritant (EC-JRC, 2009). Hence, it
remains to be seen whether they will remain
as AS of biocides in the EU market as the imple-
mentation of the BPD is completed. Overall,
the views and response of the industry to emer-
ging regulations is difficult to anticipate when
evaluating the possible benefits be gained by
a new regulatory instrument (Pearce and Koun-
douri, 2004). This is clearly a critical issue as
development of safer chemistries and substi-
tution with less hazardous alternatives is an
industry decision and choice.
The biocide industry, i.e. suppliers of bioci-
des and biocide AS, has stated that the deve-
lopment of new AS is not economically feasi-
ble, due to the regulatory demands which pose
strict requirements for product safety and effi-
cacy testing (Lindner, 2005; Bruns et al., 2005).
Accordingly, the aim of the present paper is
to elucidate the most significant obstacles and
possibilities for product development of new
AS by clarifying whether the industry views
AS development as technically feasible, what
kinds of AS’s are needed and, more specifical-
ly, what are the drivers for new AS develop-
ment as seen by the industry? Moreover, the
study evaluated whether regulatory issues
have prevented the development of the desi-
red AS’s and more specifically, can define
demands of the BPD be identified as obstacles
of the development? Furthermore, the cost
structure of possible new AS product develop-
ment was evaluated, for which no previous
published data is available. The present study
also strives to identify the approximate mag-
nitude of costs that may be viewed as intole-
rable for new AS development within the EU
in accordance with previous statements by
the industry (Bruns, 2005), and to present an
estimate of the cost level which could be tole-
rable to the industry.
Theoretical Background
Chemical regulations e.g. REACH aim at
reducing the environmental and health risks
associated with, or due to, chemicals. Benefits
of regulatory actions are primarily aimed at
reducing health expenditures caused by che-
mical exposure (EC, 2006; Pearce and Koun-
douri, 2004). On the other hand, we argue that,
in the case of biocides, reduction of risk of the
chemical substance is tied to increasing in risk
of product spoilage or biodeterioration by
unwanted organisms. Clearly, such results will
constitute a financial risk for the industry but
may also cause health risk to industry wor-
kers or consumers (Ludensky, 2005; Scholtys-
sek, 2005). These factors emphasize the com-
plex repercussions of reduction of chemical
risks. Moreover, the BPD also states “[...] when
properly used for the purpose intended, they
are sufficiently effective and have no unac-
ceptable effect [...] such as resistance develop-
ment [...] no unacceptable effect on the envi-
ronment and, [...] health.”(EC, 1998). Hence,
reduction of the chemical risks of biocides may
not be acceptable if it results in reduced effi-
cacy towards unwanted organisms.
Consequently, the risks of; 1) over regulati-
on of a substance with minor hazards or 2)
under regulation of a notably hazardous sub-
stance (Koch and Ashford, 2006) is clearly a
very relevant issue with reference to biocide
regulation and risk management. Accordin-
gly, we also present that the hazard of a bio-
cide must be evaluated with reference to the
balance sought between acceptable of tolera-
ble chemical vs. biological risk. Undoubtedly,
the industry will need to approach such an
evaluation based on economic sustainability.
Moreover, development of resistance of the
target organisms is a specific risk which is only
associated with the biocidal chemical. Nota-
bly, as the target organisms are continuously
exposed to the same of similar chemicals at a
steady concentration, i.e. chemical risk is con-
stant, the risk of development of resistance to
the chemical will increase (Maillard, 2002).
Elina Kähkönen,Teemu Hirvonen and Katrina Nordström
Journal of Business Chemistry 2010, 7(2)© 2010 Institute of Business Administration 70
Avoiding or mitigating such an increased risk
of resistance development could, however, be
avoided by development of new AS. The new
AS may even be equivalent to chemical risk of
current AS, but would offer an alternative for
reducing the biological risk. It is therefore wit-
hin this context that we will approach the
question of enhancing innovation and new
product development and current stagnated
new AS development. Our theoretical frame-
work therefore supports the arguments of
Frohwein and Hansjürgens (Frohwein and
Hansjürgens, 2005), who demonstrated that
the Porter hypothesis for regulation as a driver
of innovation and new product development
may not be directly apply to the chemical
industry.
Methods and Approach
The data was gathered by interviewing 14
representatives of the International Biodete-
rioration Research Group (IBRG) in 2008. The
IBRG is an organization founded under the
Organisation of Economic Co-operation and
Development (OECD), in 1968 (IBRG, 2009). Its
members are representatives of industrial users
of biocides, biocide manufacturers, testing
laboratories from both the private and govern-
ment sector and academic institutions. A total
of ten IBRG experts participated in an oral
interview, of which 2 gave answers jointly,
giving a total of 9 complete interviews. These
ten experts represented companies with a mar-
ket share of over 50 % of the global biocide
market (Anon, 2008a). Moreover a question-
naire was filled in by 4 other IBRG members.
These replies to questionnaires were obtained
from a global biocide company (1), a
small/medium sized European biocide com-
pany (1), a European microbiological service
provider (1), and a European research institu-
te (1). All interviewees described their roles in
the organization by defining how much their
work is related to microbiological testing, bio-
cide development, EHS/ biocide regulations
and customer support (figure 1.)
The nine biocide supplier interviews were
composed of (i) direct questions, (ii) statements
and semi-quantitative questions and (iii) a
table to fill in during the interview. For ana-
lysis of data, the answers to direct questions
(n=6) (oral and written) were expressed as
numbers of similar answers/total number of
answers. With reference to statements such
as e.g. “Implementation of BPD will lead to the
following”, interviewees were instructed to
reply whether they agreed or disagreed by
choosing from the following: 0 = not at all; 1
= to minor extent; 2 = to some extent; 3 = com-
pletely. Seven statements were presented, of
which 3 focused on comparing biocide appli-
cations in antifouling, treated wood, process
waters, masonry coatings, cosmetics, plant
protecting agents, foodstuffs and disinfecti-
on (and other areas, if needed). It is evident
that some of these application areas are not
within the scope of the BPD, i.e. cosmetics,
foodstuffs and plant protecting products (EC,
1998). These areas are under different regula-
tions, however, analysis of such regulations
were beyond the scope of this paper. Conse-
quently, these areas of application were only
included from the point of view of the possi-
bility that a concerted effort towards new AS
in these application areas could have signifi-
cance as a driver for the development of a new
AS also in applications within the scope of the
BPD.
The results were summarized as a) the num-
ber of replies for naming each application and
b) the value given (0-2). Answers on applica-
tions were expressed as a number of replies /
total number of answers in all the applicati-
ons. Finally, the interviewees were also reques-
ted to fill in a table of the development costs
of a new AS’s and of new biocidal product deve-
lopment. The estimates were given either as
direct cost (€ or $) or as proportion of the total
cost (%). Cost evaluation for vertebrate testing
in accordance with BPD was calculated inde-
pendently from the interviews. The calculati-
ons are based on data obtained from an inter-
national testing services company (Anon,
2008b). The lowest cost alternatives for the
tests were used for different means of admi-
nistration (dietary, gavage, dermal). Moreover,
the price for one exposure concentration (ins-
tead of 3 concentrations) was used for acute
inhalation toxicity. Cost of preliminary tests
as well as costs of tests for finding the preli-
minary dose range were omitted form the cal-
culations as they are not included in direct
test requirements (EC, 1998). Costs for muta-
genicity studies were also not included assu-
ming that prior studies in vitro give adequa-
te result. Costs were converted to Euros (1 GBP
= 1.253 €, 24.10.2008).
Limitations of the Study
The structure and the approach of the pre-
sent study set certain limitations. First, the
number of interviewees is limited and can not
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be stated to represent the whole biocide sup-
plier industry. On the other hand, the data col-
lected represents views of major actors of the
EU biocide markets and the individuals inter-
viewed had an average of at least 20 years
experience in the field in many areas of expe-
rience and responsibility (figure 1).
Therefore, the data presented in this study
may be viewed as an indication of leading
industry perspective with relevance to current
and future trends in the EU. Moreover, as these
trends are not the topic of scientific publica-
tions in general, very little previous data is
available for such an industry perspective.
Second, an estimation of the economic feasi-
bility of new AS development does not take
into account potential revenues. This decisi-
on was made, as the aim was to focus specifi-
cally on the structure of the development costs
and on the share of the costs related to the
regulatory requirements, which have been
identified as a major obstacle for new AS deve-
lopment (Bruns, 2005). Moreover, we have
addressed the issue of development of new AS
profitability (EU) in a previous study (Soirin-
suo, 2009). Thus, taking the above limitations
into account, the present study offers an indus-
try based perspective on the drivers, challen-
ges and trends of development of new AS in
the framework of EU regulations, with speci-
fic reference to the implementation of the BPD.
Results and Discussion
Drivers of New AS Development 
Fulfilling the technical requirements on
new biocide AS is a challenge as they should
be harmful to living organisms, but at the same
time, be safe for humans and the environment
(EC, 1998).  However, regardless of this dilem-
ma, all the interviewees agreed either most-
ly (7/13) or fully (6/13) that it is technically pos-
sible to develop new and better AS’s. Regula-
tory costs were the most notable arguments
against new AS development (4/13). 
With regard to the need for new AS’s for
different applications, the majority stated that
there is a need for new AS development (table
1). Only a small proportion answers indicated
“no need” (5/92) and the majority indicated
some need (45/92) or a clear need (42/92).
Moreover, the majority saw a clear need for
new AS development in antifouling products
(9/12) and in plant protecting agents (8/10).
The interviewees were also asked to describe
the kinds of specifications that new develop-
ment should strive for. Based on the answers
it became evident that improved safety (wit-
hout loosing efficacy) is clearly the most impor-
tant driver for development of new AS’s (11/24).
Improvement of efficacy, avoiding the emer-
gence of resistant strains, and widening of the
available biocide selection was of equal impor-
tance respectively  (3/24). A few interviewees
also stated  that  price performance and con-
sumer acceptance are of importance (2 /24 for
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Figure 1 Level of expertise and areas of responsibility as indicated by interviewees
Number of
replies
Low HighLevel of expertise
0
1
7
6
5
4
3
2
Microbiological tests
Biocide development
EHS / biocide regulation
Customer support
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each). Accordingly, based on the above data,
it is evident that development of a new, safer
biocide is considered important and also tech-
nically feasible. Non-chemical means for con-
trol of biodeterioration were not perceived as
viable alternatives nor as significant compe-
titors for traditional AS based chemical bioci-
des.
Regulatory demands and BPD: Present challen-
ges
The EU biocide industry is inherently tied
to the BPD. A central goal for the BPD is sim-
plification of the national biocide regulations
in the EU, none of which covers all the bioci-
de application included in BPD (OECD, 1999;
EC, 1998). Other aims include the harmoniza-
tion of biocide regulations in the EU, enabling
free circulation of  biocidal products, minimi-
zing vertebrate testing and minimizing the
Environment, Health and Safety (EHS) risks of
biocide usage (EC, 1998). It is therefore evident
that the present status and future expectati-
ons related to BPD implementation and
impacts thereof play a pivotal role in new AS
development. Accordingly, the present study
focused on elucidating expectations of the
industry as to how well such aims will be
accomplished via the implementation of the
BPD (table 2). 
The minority of interviewees were of the
opinion that implementation of the BPD would
lead to simplification of biocide regulation
(5/13) and only a few regarded harmonization
as being completely achievable (4/11) or to take
place at least to some extent (5/11). All the inter-
viewees expected that the free circulation of
biocidal products would be enhanced at least
to some extent after the implementation of
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Application 0 1 2 Total Examples of the developement specifications (number of replies)
Antifouling 3 9 12 Safer than TBT (1) / Cu (1)
Treated wood 7 6 13
Replacement for CCA (1)
Safer than DCOITa, Cu (1)
Process waters 2 8 2 12 Safer than CIT/MITb, phenolics (1)
Masonry coatings 6 5 11 Safer than diuron, terbutyryn (1) Alternatives for algicides / in highpH coatings (2)
Cosmetics 2 6 4 12
Safer than parabens, CIT/MIT, FDc (1)
More efficient than parabens (1) Approved by consumer (2) 
Alternatives in creams (1)
Agents 2 8 10 Safer than glutaraldehyde, FD (1)
Foodstuffs 6 4 10 More efficient than benzoic acid, sorbic acid (1)
Disinfection 1 7 4 12 More efficient than QUAT
d (1)
Efficacy against resistant strains (1)
Total 5 45 42 92
Specifications in general:
More efficient (1)
Price performance (1) / in organic fungicides (1)
Improved safety (2) / compared to ITe (1)
Avoiding resistant strains (2)
Multifunctional (1)
0 = no need, 1 = some need, 2 = clear need
Table 1 Need for a new AI development in different applications
a)  DCOIT = 4,5-Dichloro-2-n-octyl-isothiazolin-3-one.
b)  CIT/MIT = Chloro-2-methyl-4-isothiazolin-3-oni / 2-methyyli-4-isotiazol-3-oni.
c)  FD = Formaldehyde Donor.
d)  QUAT = QUATernary ammonium compounds.
e)  IT = Iso Thiazolone.
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BPD. Only some of the interviewees believed
that the BPD would lead to a slight reduction
in the number of animal tests (3/13), whereas
a more significant reduction was predicted by
others (5/11) “No reduction at all” replies (3/13)
may reflect views on the situation during the
ongoing implementation of the BPD, whereas
other interviewees may have referred more to
the expectations after the implementation.
Two interviewees stated that number of the
animal tests will reduce only after the review
process. Half of the general comments on BPD
described the BPD as “complicated” or by simi-
lar terms (6/12). It was also emphasized that
in-house expertise (3/12) and advice from the
authorities (5/12) will be imperative for suc-
cessful management of BPD implementation
at company level. On the other hand, a few
stated that communication with the authori-
ties is often not successful (2/12) and one inter-
viewee concluded that currently also the aut-
horities are part of the learning process. It is
to be expected that as both authorities and
industry proceed in this learning process
during the implementation of the BPD, under-
standing of the regulation will improve, and
the perceived complexity of regulation may
decrease.
Impact of the BPD Implementation on Availa-
ble AS on the Market 
Impact of the implementation of the BPD
on the AS selection on the market was evalua-
ted by asking interviewees to name important
or interesting AS that are likely to be removed
from the EU market due to the implementati-
on of the BPD. Many of the replies to this ques-
tion (4/7) identified formaldehyde and/or form-
aldehyde donors (FD). These chemistries are
used in numerous applications such as in-can
preservation of different products such as poly-
mer dispersions and paints as well as in pro-
cess fluid preservation e.g. in the pulp and
paper industry. “Safer than FD” was also given
as one specification for new AS development
(table 1). No other out-phased AS chemistries
were named as important or interesting by
more than one respondent. 
Cost Structure of AS and Biocidal Product Deve-
lopment 
The cost of implementation of regulatory
demands has been named as one of the main
reasons for stagnant development of new AS
(Bruns et al. 2005). Therefore, the aim of this
part of the interview was to arrive at a nume-
ric value for what is considered an intolerable
cost level for new AS development and what
kind of cost estimates would be tolerable. It is
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Outcome 0 1 2 3 Total Comments
Simplification of biocide regulati-
ons in the EU 3 5 4 1 13
Harmonization of biocide regula-
tions in the EU 1 1 5 4 11
Harmonization not complete becau-
se member states are sticking to
national interpretations (2)
Free circulation of the biocides in
the EU 0 4 3 4 11
Minimizing the number of animal
tests 3 1 3 5 13
Minimization due to data sharing (2)
Minimization only after the imple-
mentation process (2)
Minimizing the EHS risks of bioci-
de use 1 6 5 1 13
Risk reduction due to out phasing of
some hazardous substances (3)
Total 8 17 20 15 61
0 = not at all, 1 = to minor extent, 2= to some extent, 3 = completely
Comments were given without further questions
Table 2 Outcomes of the BPD implementation
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to be noted that unlike new AS, new biocidal
products are being developed and thus it may
be argued that the costs of biocides develop-
ment are tolerable. The cost structure of the
development of a new AS was based on an
analysis of data from the oral interviews and
the 7 tabular cost estimations given by res-
pondents (table 3). Four of the estimates were
given by interviewees as costs (€/$) and three
as proportions (%). It is evident (table 3) that
the difference between the tolerable cost
structure of biocidal products and the intole-
rable AS development costs is vast (table 3).
Interviewees estimated the total cost of a new
AS development and a new biocide as being
in the range of M€ 2.7- 3.8 (3/4) and M€ 0,1 and
0,6  respectively (4/4). In both cases, the majo-
rity of interviewees allocated the main share
of the costs to regulatory requirements such
as EHS risk evaluation, dossier composition
and the registration fee 7/7 for AS and 4/7 for
biocidal product development). For new AS
development the majority (3/4) estimated  the
cost as being between M€ 2.2 and 3.5 for EHS
risk evaluation including the dossier compo-
sition. This falls in the same range as the ear-
lier results obtained by Gartiser et al. (Garti-
ser et al. 2007). The one exception of the inter-
viewees estimated the cost as being even hig-
her. During the present study, independent of
the interviews, we calculated that vertebrate
testing would be in the range of M€ 2.4 (Anon,
2008b), for AS testing to fulfill requirements
of the BPD. Clearly, these regulatory demands
become a major cost factor. Interviewees esti-
mated the costs related to EHS risk evaluati-
on and dossier composition of new biocidal
product development as either € 50,000 (2/4)
or € 300,000 (2/4). These regulatory issues are
also inherently tied to vertebrate testing, with
a cost estimate of € 40,000. It may thus be con-
cluded that as the main costs of new AS deve-
lopment are directly linked to EHS risk evalua-
tion testing, a critical challenge is how to redu-
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Action Proportion (cost when available)
Active substance % (1000 €) Average
Development 20 (600) 3 (72) 10 (2,000) 1 (50) 5 15 25 11
EHS risk evaluation 70 (2,100) 82 (2,160) 75 (15,000)
93 (3,500)
50
60
25
83Dossier composition 5 (150) 1 (36) <5 (1,000) 20 25
Registration fee in the EU 5 (150) <1a (7) <5 (1,000) 5 b (200) 10 25
Other (manufacture) 13 (360)
6Other (not specified) 5
Other (customer work and method development) 25
Total cost for AI (1,000 €) 3,000 2,635c 20,000 3,750 - - - 3,150d
Biocidic product % (1000 €) Average
Development 25 (150) 15 (72) 10 (50) 8 (9) 20 50 50 25
EHS risk evaluation tests according to regulations 25 (150) 8 (36) 50 (250)
48e (55)
30
50 50 60Dossier composition 25 (150) 2 (7) 10 (50) 40
Regestration fee in the EU 25 (150) n. a. <5 (<25) 43 (50) 10
Other (manufacture) 76 (360)
14
Other (marketing) 25 (125)
Total cost for biocidial product (1000 €) 600 475 500 115 - - - 422
a)  The registration fee in the US.
b)  The original data was given as 82 - 320,000 €, of which average is presented. 
c)  The original values were given USD and converted into Euros (1 USD = 0.72 €). 
d)  The clearly differing value (20 M€) was left out of the average calculation. 
e)  The original data was given as 50 - 60,000 €, of which the average is presented.
Table 3 Cost structure of the development
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ce these costs without the subsequent increa-
se of the EHS risks which the evaluation spe-
cifically strives to control.
Avoiding Possible Stagnation of AS Develop-
ment
The interviewees stated that simplificati-
on of the regulation is almost as important as
cost reduction in enabling new AS develop-
ment. Harmonization of different regulations
or extended permanence of the chemical risk
classification (R-phrases, warning labels), were
not considered as important. Other regulato-
ry issues that interviewees also stated as sup-
porting interest in new AS development were
improved Intellectual Property Rights (IPR)
protection (1) and reduction in data require-
ments in accordance with reduced volumes as
implemented under REACH (Regulation (EC))
No 1907/2006 on Registration, Evaluation, Aut-
horisation and Restriction of Chemicals) (1).
In order to shed light on the more concre-
te direction on the kinds of regulatory changes
that the industry is calling for, the intervie-
wees were asked to name an example of a
satisfactory registration procedure of biocides
or other chemicals, which also provides ade-
quate safety and environmental information.
Interviewees responded by naming the U.S.
Environmental Protection Agency (EPA) bioci-
de registration as a sole positive example of
such procedures (5/8) as it is considered as
being better understood and communicated
by both the authorities and the industry (3/8).
The other positive aspects of the EPA biocides
procedure were better protection of Intellectu-
al Property Rights (IPR) and being based on
risk assessment instead of the precautionary
principle.  This principle comprises a model of
anticipatory to protect humans and the envi-
ronment against uncertain risks of human
action (UNESCO, 2005). One comment summa-
rized the EPA procedure as being “more
straightforward” as it has been in operation
for a longer period of time and thus is better
comprehended. Of the respondents who men-
tioned EPA as the positive example, 3/5 were
US-based and the rest (2/5) were based in
Europe. Nevertheless, the stagnation of new
AS development is also a concern in the US
even though the regulatory process may be
considered more acceptable. 
As the simplification of the regulation was
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0 1 2 3 Total
Changes in regulatory
network
Simplified market entry with the new biocidic pro-
ducts 0 0 4 9 13
Cheaper process for market entry 0 0 3 10 13
Harmonization of the requirements between the
different directives on biocides (plant protecting
agents, cosmetics, foodstuffs, BPD)
1 1 6 5 13
Extended permanence of a chemical risk classifica-
tion 3 3 4 2 12
Other changes proposed (number of comments):
Reduced test requirement along with reduced volumes (1)
Improved IPR protection (1)
Basic research area
Determination of biocide efficacy 1 2 10 13
Determining biological activity and mechanisms of
the biocides 2 7 4
13
Determination of biocide toxicity and ecotoxicity 1 2 10 13
Determination of microbial succession in biodete-
rioration and biodegradation 2 3 4 3 12
Other areas considered important (number of comments):
Exposure scenarios (1)
Cost efficiency (2)
Biocide & non-biocide combinations to reduce contamination (1)
0 = not important at all, 1 = very little importance, 2 = quite important, 3 = very important
Table 4 Changes in the regulatory network necessary for facilitating development of new AI  and the importance of the
basic research for promoting such development
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considered a priority for new AS development,
the BPD’s objective to simplify EU biocide regu-
lation is well in line with such demands. Pre-
sently, however, this has not been accomplis-
hed, as the industry considers the BPD com-
plicated. Moreover, the expected future sim-
plification, via learning by experience as the
implementation proceeds, may be seriously
hindered by adhering to national interpreta-
tions (table 2).
Cost Reduction – Minimizing Toxicity Tests
Reduction of costs was ranked as the most
important factor for  promoting development
of new AS (table 4) where  cost reduction is
directly influenced by requirements for toxi-
city testing (table 3). Consequently, basic
research in toxicity should be considered equal-
ly as important as biocide efficacy itself, which
is the most essential and inherent property of
biocides. Notably, in the present study, only
one interview indicated “no importance at all”
for toxicity and eco toxicity research. At the
same time this particular respondent ranked
exposure scenario research as important, which
supports the view on the importance of che-
mical risks assessment as such. 
The clear majority of the interviewees
expected a reduction of animal tests to take
place after the implementation of the BPD
(table 2). Surprisingly perhaps, only one reply
suggested similar tonnage trigger structure
permitting reduced data requirement with
reference to smaller volume as stipulated by
REACH (EC, 2006). In conclusion, more targe-
ted toxicity testing research and transparent
data on such testing is an important driver for
new AS development. 
Conclusions
The ultimate goal for new AS development
is a “safer than” chemistry of that of an exis-
ting AS. The present study indicates that bio-
cide suppliers view the development of such
new AS as technologically feasible and there
is a definite need for new AS development in
many application areas. However, to enable
such development simplification of biocide
regulation and tolerable development costs
are essential. Although simplification of the
placement of biocidal products on the EU mar-
ket is also an important aim of the BPD, indus-
try representatives interviewed in this study
were doubtful on accomplishing such a goal.
Simplicity of a regulation involves also fluen-
cy of communication between the authorities
and the industry as exemplified by the functio-
ning of the EPA procedures, with emphasis on
direct communication between the parties. In
the EU, however, such communication and
interaction poses a challenge, as a vast num-
ber of national authorities of 27 Members
States, are trying to harmonize their work and
agree on a common agenda for the interpre-
tation of the regulations (Gartiser, 2007). Con-
sequently, national authorities are largely
responsible for the implementation of the regu-
lations and thus play a dominant role in the
subsequent communication between all play-
ers in the field. According to the present study,
it appears that the authorities are considered
to be in a learning stage with BPD practices
and thus their support for the industry may
not be adequate at this time. It remains to be
seen what impacts the recent simplification
of the registration and centralization of  part
of the process under the  European CHemical
Agency (ECHA) will have in the future (COM,
2009). 
The costs of toxicity testing on vertebrates
according to regulatory requirements were
named as the most demanding requirements
of new biocides development and basic
research in this area was called for. The pre-
sent study arrived at a cost estimate of 2,400
000 € for vertebrate tests, which represents a
major share of the approximately 3,000,000
€ of the total cost of development. Although
these estimates are only approximations, it is
evident that such cost structure together with
the ethical considerations gives strong sup-
port for the goals of minimizing of vertebra-
te testing as stipulated by both the BPD and
REACH. However a dilemma still exists as, on
one hand, both the BPD and REACH consider
these tests as the best and most reliable
method for evaluating toxicity and eco toxi-
city, and few alternatives to such testing are
currently available. On the other hand, the test
requirements for the highest tonnage substan-
ces in REACH are reduced compared to the
requirements for AS in the BPD. For example
REACH defines the chronic toxicity studies on
one species as being adequate, while the BPD
requires testing in a rodent and a non-rodent
species (EC, 1998 and EC, 2006). A step forward
has, however, been taken as both BPD and
REACH strongly guide data sharing of verte-
brate tests in order to avoid multiple testing.
According to the interviewees in the present
study, such guidance via the BPD were also
expected to result in concrete actions of mini-
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mizing animal tests. In the case of REACH, the
implementation of the obligatory data sha-
ring is verified by centralized control by the
European Chemicals Agency (ECHA) of the sub-
stances registered. Other data holders than
industry may also share the relevant data after
the preregistration. Moreover, the possibili-
ties of using alternative test methods or omit-
ting test usage are emphasized in the case of
REACH as the Annex XI addresses on the alter-
natives such as read across of similar substan-
ces, Quantitative or Qualitative Structure-Acti-
vity Relationship ((Q)SAR) and in vitro testing
and recommends their  use wherever applica-
ble. Furthermore, complete omission of tes-
ting is also acceptable in cases where prior
data on human exposure results is available,
or the likelihood of only limited exposure can
be demonstrated. In the case of BPD similar
listing is found in a Technical Guidance Docu-
ment (ECB, 2000). Finally, in REACH, the reducti-
on of the test requirements accompanied by
reduced market volumes of the substances ser-
ves the same objective and is equally impor-
tant in permitting new, small volume chemi-
cals to be brought onto the EU market (EC,
2006). 
In conclusion, concise and economically
feasible chemical regulation without increa-
sing EHS risks with reference to use of chemi-
cals may not necessarily be a “Mission Impos-
sible”, even though by first glance it certain-
ly appears to be. Active communication bet-
ween the authorities and industry is a powerful
tool for simplifying emerging regulations and
their implementation. Decreasing the cost
effects of the regulatory demands is a major
hurdle, as it calls for development of methods
for replacing the most expensive toxicity tests.
Thus, research and development of alternati-
ve, less expensive test methods is pivotal for
the development needs of the chemical indus-
try at large. A number of assumptions have
been made in the present study and the trends
that we have identified are open for anyone
to challenge. As stated also by Pearce and Koun-
douri (Pearce and Koundouri, 2004) clearly
more superior assumptions can be generated,
as the methodology, the data and the limita-
tions of the present study have been made
transparent. On the other hand, even as the
results of the present study carry merely indi-
cative value, our arguments are very much in
line with recent views by Hartung (2009) on
the need for development of new testing
methods. Hartung (2009) calls for concrete
actions in the form of substantial funding for
academic and non -governmental organizati-
on for the development of such new methods.
This underlines the global importance of
REACH in exploring an arsenal of tools to redu-
ce the number of vertebrate tests and pushing
forth alternative test method development.
Consequently, REACH has set the stage for
development of tools for the biocide industry
for enabling economically sustainable deve-
lopment of safer biocides. 
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